162 related articles for article (PubMed ID: 17952685)
1. MR imaging and proton spectroscopy of the breast: how to select the images useful to convey the diagnostic message.
Fausto A; Magaldi A; Babaei Paskeh B; Menicagli L; Lupo EN; Sardanelli F
Radiol Med; 2007 Oct; 112(7):1060-8. PubMed ID: 17952685
[TBL] [Abstract][Full Text] [Related]
2. Three-phase dynamic breast magnetic resonance imaging with two-way subtraction.
Choi N; Han BK; Choe YH; Kim HS
J Comput Assist Tomogr; 2005; 29(6):834-41. PubMed ID: 16272861
[TBL] [Abstract][Full Text] [Related]
3. [Comprehensive magnetic resonance imaging for breast cancer].
Meladze NV; Ternovoĭ SK; Sharia MA; Solopova AE
Ter Arkh; 2013; 85(4):29-33. PubMed ID: 23808288
[TBL] [Abstract][Full Text] [Related]
4. Automatic identification and classification of characteristic kinetic curves of breast lesions on DCE-MRI.
Chen W; Giger ML; Bick U; Newstead GM
Med Phys; 2006 Aug; 33(8):2878-87. PubMed ID: 16964864
[TBL] [Abstract][Full Text] [Related]
5. Detection of breast malignancy: diagnostic MR protocol for improved specificity.
Huang W; Fisher PR; Dulaimy K; Tudorica LA; O'Hea B; Button TM
Radiology; 2004 Aug; 232(2):585-91. PubMed ID: 15205478
[TBL] [Abstract][Full Text] [Related]
6. Breast lesion detection and characterization at contrast-enhanced MR mammography: gadobenate dimeglumine versus gadopentetate dimeglumine.
Pediconi F; Catalano C; Occhiato R; Venditti F; Fraioli F; Napoli A; Kirchin MA; Passariello R
Radiology; 2005 Oct; 237(1):45-56. PubMed ID: 16126926
[TBL] [Abstract][Full Text] [Related]
7. Combined dynamic contrast enhanced breast MR and proton spectroscopic imaging: a feasibility study.
Jacobs MA; Barker PB; Argani P; Ouwerkerk R; Bhujwalla ZM; Bluemke DA
J Magn Reson Imaging; 2005 Jan; 21(1):23-8. PubMed ID: 15611934
[TBL] [Abstract][Full Text] [Related]
8. MR breast imaging: a comparative analysis of conventional and parallel imaging acquisition.
Orlacchio A; Bolacchi F; Rotili A; Cossu E; Tanga I; Cozzolino V; Simonetti G
Radiol Med; 2008 Jun; 113(4):465-76. PubMed ID: 18523845
[TBL] [Abstract][Full Text] [Related]
9. [Subtraction and dynamic MR images of breast cancer].
Murakami Y; Aoki M; Harada J
Nihon Igaku Hoshasen Gakkai Zasshi; 1993 Apr; 53(4):375-86. PubMed ID: 8493070
[TBL] [Abstract][Full Text] [Related]
10. Background parenchymal enhancement in pregnancy-associated breast cancer: a hindrance to diagnosis?
Taron J; Fleischer S; Preibsch H; Nikolaou K; Gruber I; Bahrs S
Eur Radiol; 2019 Mar; 29(3):1187-1193. PubMed ID: 30229271
[TBL] [Abstract][Full Text] [Related]
11. Optimal T2-weighted MR cholangiopancreatographic images can be obtained after administration of gadoxetic acid.
Kim KA; Kim MJ; Park MS; Lim JS; Choi JY; Hong HS; Kim KW
Radiology; 2010 Aug; 256(2):475-84. PubMed ID: 20656837
[TBL] [Abstract][Full Text] [Related]
12. Digital mammography using iodine-based contrast media: initial clinical experience with dynamic contrast medium enhancement.
Diekmann F; Diekmann S; Jeunehomme F; Muller S; Hamm B; Bick U
Invest Radiol; 2005 Jul; 40(7):397-404. PubMed ID: 15973130
[TBL] [Abstract][Full Text] [Related]
13. Measurement of carotid wall volume and maximum area with contrast-enhanced 3D MR imaging: initial observations.
Zhang S; Cai J; Luo Y; Han C; Polissar NL; Hatsukami TS; Yuan C
Radiology; 2003 Jul; 228(1):200-5. PubMed ID: 12832583
[TBL] [Abstract][Full Text] [Related]
14. Is there a correlation in breast carcinomas between tumor size and number of tumor vessels detected by gadolinium-enhanced magnetic resonance mammography?
Siewert C; Oellinger H; Sherif HK; Blohmer JU; Hadijuana J; Felix R
MAGMA; 1997 Mar; 5(1):29-31. PubMed ID: 9219176
[TBL] [Abstract][Full Text] [Related]
15. Fusion of dynamic contrast-enhanced magnetic resonance mammography at 3.0T with X-ray mammograms: pilot study evaluation using dedicated semi-automatic registration software.
Dietzel M; Hopp T; Ruiter N; Zoubi R; Runnebaum IB; Kaiser WA; Baltzer PA
Eur J Radiol; 2011 Aug; 79(2):e98-e102. PubMed ID: 21570793
[TBL] [Abstract][Full Text] [Related]
16. Hepatic abscesses. Magnetic resonance imaging findings using gadolinium-BOPTA.
Runge VM; Wells JW; Williams NM
Invest Radiol; 1996 Dec; 31(12):781-8. PubMed ID: 8970881
[TBL] [Abstract][Full Text] [Related]
17. [Combination of low and high resolution T1-weighted sequences for improved evaluation of morphologic criteria in dynamic contrast enhanced MRI of the breast].
Vomweg TW; Teifke A; Schreiber WG; Schmidt M; Thelen M
Rofo; 2002 Nov; 174(11):1445-9. PubMed ID: 12424673
[TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance spectroscopy of the breast at 3T: pre- and post-contrast evaluation for breast lesion characterization.
Kousi E; Tsougos I; Vasiou K; Theodorou K; Poultsidi A; Fezoulidis I; Kappas C
ScientificWorldJournal; 2012; 2012():754380. PubMed ID: 22645448
[TBL] [Abstract][Full Text] [Related]
19. The evaluation of human breast lesions with magnetic resonance imaging and proton magnetic resonance spectroscopy.
Cecil KM; Schnall MD; Siegelman ES; Lenkinski RE
Breast Cancer Res Treat; 2001 Jul; 68(1):45-54. PubMed ID: 11678308
[TBL] [Abstract][Full Text] [Related]
20. A preliminary study on computerized lesion localization in MR mammography using 3D nMITR maps, multilayer cellular neural networks, and fuzzy c-partitioning.
Ertas G; Gulcur HO; Tunaci M; Osman O; Ucan ON
Med Phys; 2008 Jan; 35(1):195-205. PubMed ID: 18293575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
